WCM
NVO

Wisconsin Capital Management’s Novo Nordisk NVO Stock Holding History

Wisconsin Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,469
Closed -$3.85M – 55
2025
Q1 		$3.85M Sell
55,469
-7,710
-12% -$637K 2.45% 19
2024
Q4 		$5.43M Sell
63,179
-3,850
-6% -$416K 2.99% 12
2024
Q3 		$7.98M Buy
67,029
+200
+0.3% +$26.7K 4.19% 7
2024
Q2 		$9.54M Hold
66,829
– – 4.83% 5
2024
Q1 		$8.58M Sell
66,829
-1,306
-2% -$155K 4.5% 6
2023
Q4 		$7.05M Sell
68,135
-643
-0.9% -$63.6K 4.19% 7
2023
Q3 		$6.25M Buy
68,778
+878
+1% +$77.3K 4.13% 7
2023
Q2 		$5.49M Buy
+67,900
New +$5.55M 3.56% 7

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wisconsin Capital Management's NVO Position: Q2 2025 in Review

Wisconsin Capital Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 55,469 shares — an estimated $3.85M sold.

Wisconsin Capital Management first reported a position in NVO in Q2 2023 and held it in 8 quarters. The position peaked at $9.54M in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Wisconsin Capital Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Wisconsin Capital Management sold 55,469 Novo Nordisk shares in Q2 2025, an estimated $3.85M.
  • Wisconsin Capital Management first reported a position in Novo Nordisk in Q2 2023 and held it in 8 quarters.
  • Wisconsin Capital Management's Novo Nordisk position peaked at $9.54M in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Wisconsin Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.